ANTIMICROBIAL THERAPY EFFICACY AGAINST E. COLI STRAIN UNCLEAR
Executive Summary
ANTIMICROBIAL THERAPY EFFICACY AGAINST E. COLI STRAIN UNCLEAR in the absence of controlled trials, according to an American Gastroenterological Association consensus conference Statement. Conference Committee Chairman Martin Brotman, MD, California Pacific Medical Center, asserted at a July 13 press conference that "we need controlled clinical trials to establish whether there is any efficacy from antimicrobial drug therapy" for those infected with E. coil 0157:H7.